Re: Financing - for those needing dental work
in response to
by
posted on
Apr 05, 2017 02:22AM
It is entirely understandable that Public Offerings are unpopular with current shareholders because of their dilutive effect on personal investment in PTI, it is an unassailable fact however, that companies, particularly venture companies, must have the PO tool available at hand to fulfill their main aims, which ultimately are in shareholders' best interest too albeit painful when it occurs.
Lumenge and Shash's posts point to another source of funding that leverages PTI'S ability to fulfil it's potential which can only happen to going concerns. Hence the importance of the aquisitions of BB and DL whose ramped up production processes have been placed at the heart of the PTI business plan. Which due to delays necessitated the dreadful PO saga of November 16.
Singapore as a hub location geographicaly and a centre of technological inovations is where funding such inovation happens and where Government grants have already backed PTI to the tune of $US 8m.
A shrewd gamble is taking place to demonstrate DL is on a clear path to success which if it works, and we have every reason to expect it will, will launch POET products in 2018 with revenue streams in late 2018 plus. As the DL drive gathers pace revenue, NRE, loans and further grants all become feasible tools to aid the capital investment necessary for success.
Once the markets have awareness of the shrewd plan unfolding and clear indications of cash flow being under control PR should by then be able to start priming the pump of expectation that POET technology's disruptive capacity is a reality as prototypes become available.
The remergence of qloomy glooms dire predictions has alway historically preceded a more in depth, realistic cheery, analysis of NR on this board and I predict that those 'kicked in the teeth' shall soon have the necessary dental treatment as it is realised that the DLplan is a good one and the PO tool is returned to its proper place in the dark recesses of the company's toolbox.
Commercialisation has many steps that must be taken in the right order and all require time. Let's accept that that timeframe is a rubber band that stretches and con tracts to a degree but for POET products it looks like late 2018 is the sweetspot.
Sula